natgillin/translations-raw huggingface dataset:
The study population had an average age of 62 years; the average duration of diabetes was 9.5 years. 
Starost populacije, vključene v študijo, je bila v povprečju 62 let; povprečno trajanje sladkorne bolezni je bilo 9,5 let.
You can usually continue to take other medicines whilst you are being treated with Glustin. 
Običajno lahko še naprej jemljete druga zdravila, medtem ko se zdravite z zdravilom Glustin.
- if you have a problem with your liver or heart. 
če imate težave z jetri ali s srcem.
Tell your doctor if - you are, you think you might be or are planning to become pregnant. 
Povejte zdravniku če ste noseči, menite, da bi lahko bili noseči ali načrtujete zanositev.
Your doctor will tell you the dose to take. 
Zdravnik vam bo predpisal odmerek, ki ga morate jemati
Use in children and adolescents under 18 years is not recommended. 
Otroci in mladostniki Uporaba tega zdravila pri otrocih in mladostnikih, mlajših od 18 let, ni priporočljiva.
The safety and efficacy of Glustin in children and adolescents under 18 years of age have not been established. 
Varnost in učinkovitost zdravila Glustin pri otrocih in mladostnikih, mlajših od 18 let, nista bili dokazani.
Approximately one third of patients were receiving insulin in combination with metformin and/or a sulphonylurea. 
Približno tretjina bolnikov je prejemala insulin v kombinaciji z metforminom in/ali sulfonilsečnino.
Glustin helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces. 
Zdravilo Glustin pomaga nadzorovati raven sladkorja v krvi, če imate sladkorno bolezen tipa 2, in sicer tako, da telesu pomaga bolje izkoristiti insulin, ki ga izdela.
What Glustin is and what it is used for 
Kaj je zdravilo Glustin in za kaj ga uporabljamo
Almost half of the patients had a previous myocardial infarction and approximately 20% had had a stroke. 
Skoraj polovica bolnikov je predhodno doživela miokardni infarkt in približno 20% jih je doživelo kap.
Glustin has no or negligible influence on the ability to drive and use machines. 
Zdravilo Glustin nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
Take Glustin daily as prescribed. 
Zdravilo Glustin jemljite vsak dan, kakor vam je predpisano.
If you take Glustin with other medicines for diabetes, it is more likely that your blood sugar could fall below the normal level (hypoglycaemia). 
Če zdravilo Glustin jemljete z drugimi zdravili za zdravljenje sladkorne bolezni, je bolj verjetno, da vrednost krvnega sladkorja pade pod normalno raven (hipoglikemija).
The observed excess risk of fractures for women in this dataset on pioglitazone is therefore 0.8 fractures per 100 patient years of use. 
Opazovano povečano tveganje za zlom pri ženskah v tej skupini podatkov na pioglitazonu je torej 0,8 zlomov na 100 bolniških let uporabe.
Talk to your doctor or pharmacist before taking Glustin (also see section 4) - if you retain water (fluid retention) or have heart failure problems in particular if you are over 75 years old. 
Pred začetkom jemanja zdravila Glustin se posvetujte z zdravnikom ali s farmacevtom (glejte tudi poglavje 4): - če zadržujete vodo (zastajanje tekočine v telesu) ali imate težave s srčnim popuščanjem, zlasti če ste starejši od 75 let.
not known (frequency cannot be estimated from the available data) - increase in liver enzymes - allergic reactions 
neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti) povišanje vrednosti jetrnih encimov alergijske reakcije
ANNEX IV SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION TO THE TERMS OF THE MARKETING AUTHORISATION(S) 
PRILOGA IV ZNANSTVENI ZAKLJUČKI IN PODLAGA ZA SPREMEMBO POGOJEV DOVOLJENJ (DOVOLJENJ) ZA PROMET Z ZDRAVILOM
Epidemiological studies have also suggested a small increased risk of bladder cancer in diabetic patients treated with pioglitazone, although not all studies identified a statistically significant increased risk. 
Tudi epidemiološke študije kažejo tudi malo večje tveganje za rak mehurja pri bolnikih s sladkorno boleznijo zdravljenih s pioglitazonom, čeprav pri vseh študijah povečanje tveganja ni bilo statistično signifikantno.
Almost all subjects (95%) were receiving cardiovascular medicinal products (beta blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II antagonists, calcium channel blockers, nitrates, diuretics, acetylsalicylic acid, statins, fibrates). 
Skoraj vsi preiskovanci (95%) so prejemali kardiovaskularna zdravila (zaviralce adrenergičnih receptorjev beta, zaviralce angiotenzinske konvertaze (zaviralce ACE), antagoniste angiotenzina II, zaviralce kalcijevih kanalčkov, nitrate, diuretike, acetilsalicilno kislino, statine, fibrate).
Other medicines and Glustin 
Druga zdravila in zdravilo Glustin
When Glustin is taken in combination with other medicines used to treat diabetes (such as insulin, chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to take a smaller dose of your medicines. 
Če boste zdravilo Glustin jemali skupaj z drugimi zdravili za zdravljenje sladkorne bolezni (kot so insulin, klorpropamid, glibenklamid, gliklazid, tolbutamid), vam bo zdravnik povedal, če morate jemati nižje odmerke teh zdravil.
Before you start taking Glustin you will have a blood sample taken to check your liver function. 
Pred začetkom jemanja zdravila Glustin vam bodo odvzeli vzorec krvi, da se preveri delovanje jeter.
5 Oedema was reported in 6-9% of patients treated with pioglitazone over one year in controlled clinical trials. 
5 O edemih so poročali pri 6-9% bolnikov, zdravljenih s pioglitazonom leto dni v kontroliranih kliničnih preskušanjih.
Pharmacotherapeutic group: Drugs used in diabetes, blood glucose lowering drugs; excl. insulins; ATC code: A10BG03. 
Farmakoterapevtska skupina: Zdravila za zdravljenje diabetesa, antidiabetiki; oznaka ATC: A10BG03
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Glustin. 
Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se pred uporabo tega zdravila Glustin posvetujte s svojim zdravnikom.
common common uncommon macular oedema not known not known not known not known not known 
občasni makularni edem neznana neznana neznana neznana
If ALT levels are increased to 3 x upper limit of normal during pioglitazone therapy, liver enzyme levels should be reassessed as soon as possible. 
Če se med zdravljenjem s pioglitazonom ravni ALT zvišajo do 3 kratne zgornje meje normalnih vrednosti, je treba ravni jetrnih encimov čim prej ponovno kontrolirati.
Although the study failed regarding its primary endpoint, which was a composite of all-cause mortality, non-fatal myocardial infarction, stroke, acute coronary syndrome, major leg amputation, coronary revascularisation and leg revascularisation, the results suggest that there are no long-term cardiovascular concerns regarding use of pioglitazone. 
Čeprav je bila študija neuspešna v povezavi z primarnimi opazovanimi dogodki, ki so zajemali umrljivost zaradi vseh vzrokov, neusodne miokardne infarkte, kapi, akutne koronarne sindrome, težje amputacije nog, koronarne revaskularizacije in revaskularizacije nog, izsledki kažejo, da v zvezi z kardiovaskularnim sistemom ni dolgoročnih pomislekov glede uporabe pioglitazona.
What Glustin is and what it is used for What you need to know before you take Glustin How to take Glustin 
Kaj je zdravilo Glustin in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Glustin Kako jemati zdravilo Glustin Možni neželeni učinki
If you have the impression that the effect of Glustin is too weak, talk to your doctor. 
Če menite, da je učinek zdravila Glustin prešibak, se posvetujte z zdravnikom.
Patients receiving pioglitazone had a mean reduction in HbA1c of 0.45% compared with those continuing on insulin alone, and a reduction of insulin dose in the pioglitazone treated group. 
Bolniki, ki so prejemali pioglitazon, so imeli povprečno znižanje HbA1c za 0,45%, v primerjavi s tistimi, ki so nadaljevali zdravljenje samo z insulinom, in znižan odmerek insulina v skupini zdravljeni s pioglitazonom.
If you accidentally take too many tablets, or if someone else or a child takes your medicine, talk to a doctor or pharmacist immediately. 
Če ste vzeli večji odmerek zdravila Glustin, kot bi smeli Če po nesreči zaužijete preveč tablet ali če kdo drug ali otrok zaužije vaša zdravila, o tem nemudoma obvestite zdravnika ali farmacevta.
Aluminium/aluminium blisters, packs of 14, 28, 30, 50, 56, 84, 90 and 98 tablets. 
Aluminij/aluminij pretisni omoti, pakiranja po 14, 28, 30, 50, 56, 84, 90 in 98 tablet.
On the basis of the scientific conclusions for glimepiride / pioglitazone hydrochloride, metformin / pioglitazone, pioglitazone the CHMP is of the opinion that the benefit-risk balance of the medicinal product(s) containing glimepiride / pioglitazone hydrochloride, metformin / pioglitazone, pioglitazone is unchanged subject to the proposed changes to the product information. 
Na podlagi znanstvenih zaključkov za glimepirid/pioglitazon hidroklorid, metformin/pioglitazon, pioglitazon odbor CHMP meni, da je razmerje med koristjo in tveganjem zdravil(-a), ki vsebuje(-jo) zdravilno(-e) učinkovinoe glimepirid/pioglitazon hidroklorid, metformin/pioglitazon, pioglitazon{ime(-na) zdravilne(-ih) učinkovine(učinkovin)} nespremenjeno ob upoštevanju predlaganih sprememb v informacijah o zdravilu.
Your doctor will ask you to have blood tests periodically during treatment with Glustin. 
Zdravnik vas bo v času zdravljenja z zdravilom Glustin naročal na redne preiskave krvi.
The tablets are supplied in blister packs of 14, 28, 30, 50, 56, 84, 90 or 98 tablets. 
Tablete so na voljo v pretisnih omotih po 14, 28, 30, 50, 56, 84, 90 ali 98 tablet.
very common (may affect more than 1 in 10 people) - decreased blood sugar (hypoglycaemia) 
zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov) znižanje ravni krvnega sladkorja (hipoglikemija)
The other side effects that have been experienced by some patients taking Glustin are: 
Drugi neželeni učinki, ki so se pojavili pri nekaterih bolnikih, ki so jemali zdravilo Glustin, so:
However, the incidences of oedema, weight gain and heart failure were increased. 
Vendar je bila incidenca edemov, pridobivanja telesne mase in srčnih odpovedi povečana.
− The other ingredients are lactose monohydrate, hyprolose, carmellose calcium and magnesium stearate. 
Pomožne snovi so laktoza monohidrat, hiproloza, kalcijev karmelozat in magnezijev stearat.
If you are following a special diet for diabetes, you should continue with this while you are taking Glustin. 
Če ste na posebni dieti za sladkorno bolezen, morate z dieto med jemanjem zdravila Glustin nadaljevati.
In an outcome study of patients with pre-existing major macrovascular disease, the incidence of serious heart failure was 1.6% higher with pioglitazone than with placebo, when added to therapy that included insulin. 
V študiji za ocenitev izida pri bolnikih z že obstoječimi težjimi makrovaskularnimi boleznimi, je bila incidenca resnega srčnega popuščanja 1,6% višja s pioglitazonom kot s placebom, dodanim k zdravljenju, ki je vključevalo insulin.
The European Medicines Agency has waived the obligation to submit the results of studies with Glustin in all subsets of the paediatric population in type 2 diabetes mellitus. 
Evropska agencija za zdravila je odstopila od zahteve za predložitve rezultatov študij z zdravilom Glustin za vse podskupine pediatrične populacije s sladkorno boleznijo tipa 2 (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
14 tablets 28 tablets 30 tablets 50 tablets 56 tablets 84 tablets 90 tablets 98 tablets 
14 tablet 28 tablet 30 tablet 50 tablet 56 tablet 84 tablet 90 tablet 98 tablet
- if you are allergic to pioglitazone or any of the other ingredients of this medicine (listed in section 6). 
Ne jemljite zdravila Glustin - če ste alergični na pioglitazon ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
- if you have had diabetic ketoacidosis (a complication of diabetes causing rapid weight loss, 
če ste imeli diabetično ketoacidozo (zaplet sladkorne bolezni, ki povzroča hitro hujšanje, siljenje na bruhanje ali bruhanje).
The improved glycaemic control is associated with a reduction in both fasting and postprandial plasma insulin concentrations. 
Izboljšan nadzor glikemije je povezan z znižanjem plazemskih koncentracij insulina tako na tešče kot po obrokih.
The effect of pioglitazone (45 mg monotherapy vs. placebo) was studied in a small 18-week trial in type 2 diabetics. 
Učinek pioglitazona (45 mg monoterapija v primerjavi s placebom) so preučevali v majhnem 18tedenskem preskušanju pri bolnikih s sladkorno boleznijo tipa 2.
The other side effects that have been experienced by some patients when Glustin is taken with other antidiabetic medicines are: 
Drugi neželeni učinki, ki so se pojavili pri nekaterih bolnikih, ki so jemali zdravilo Glustin skupaj z drugimi antidiabetičnimi zdravili, so:
A cardiovascular outcome study of pioglitazone has been performed in patients under 75 years with type 2 diabetes mellitus and pre-existing major macrovascular disease. 
Študijo s pioglitazonom, kjer so spremljali kardiovaskularni izid so opravili pri bolnikih, mlajših od 75 let, s sladkorno boleznijo tipa 2 in že obstoječimi težjimi makrovaskularnimi boleznimi.
If you forget to take Glustin 
Če ste pozabili vzeti zdravilo Glustin
What Glustin looks like and contents of the pack 
Izgled zdravila Glustin in vsebina pakiranja
common (may affect up to 1 in 10 people) - headache - dizziness - joint pain - impotence - back pain - shortness of breath - small reduction in red blood cell count - flatulence uncommon (may affect up to 1 in 100 people) - sugar in urine, proteins in urine - increase in enzymes - spinning sensation (vertigo) - sweating - tiredness - increased appetite 
pogosti (pojavijo se lahko pri največ 1 od 10 bolnikov) glavobol omotica bolečine v sklepih impotenca bolečine v hrbtu težko dihanje majhno znižanje števila rdečih krvnih celic vetrovi občasni (pojavijo se lahko pri največ 1 od 100 bolnikov) sladkor v urinu, beljakovine v urinu povišanje vrednosti encimov občutek vrtenja (vrtoglavica) znojenje utrujenost povečan apetit
Environmental Risk Assessment (ERA) No environmental impact is anticipated from the clinical use of pioglitazone 
Ocena tveganja za okolje: Pri klinični uporabi pioglitazona ni pričakovati vpliva na okolje
- hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - cardiac failure or history of cardiac failure (NYHA stages I to IV) - hepatic impairment - diabetic ketoacidosis - current bladder cancer or a history of bladder cancer - uninvestigated macroscopic haematuria 
- s preobčutljivostjo na zdravilno učinkovino ali katero koli pomožno snov, navedeno v poglavju 6.1 - s srčnim popuščanjem ali srčnim popuščanjem v anamnezi (NYHA razredi od I do IV) - z okvarjenim delovanjem jeter - z diabetično ketoacidozo z rakom mehurja ali rakom mehurja v anamnezi z neraziskano makroskopsko hematurijo
If you experience this symptom for the first time, talk to your doctor as soon as possible. 
Če ste prvič opazili ta simptom, se čim prej posvetujte z zdravnikom.
In comparator groups addition of sulphonylurea to metformin resulted in a mean weight gain of 1.3 kg and addition of metformin to a sulphonylurea a mean weight loss of 1.0 kg. 
V primerjalnih skupinah je dodatek sulfonilsečnine metforminu povzročil povprečno povečanje telesne mase za 1,3 kg in dodatek metformina sulfonilsečnini povprečno zmanjšanje telesne teže za 1,0 kg.
In PROactive, a cardiovascular outcome study, 5,238 patients with type 2 diabetes mellitus and pre-existing major macrovascular disease were randomised to pioglitazone or placebo in addition to existing antidiabetic and cardiovascular therapy, for up to 3.5 years. 
V PROaktivni študiji, ki ocenjuje kardiovaskularni izid, je bilo 5.238 bolnikov s sladkorno boleznijo tipa 2 in že prej obstoječimi težjimi makrovaskularnimi boleznimi naključno dodatno zdravljenih s pioglitazonom ali placebom k že obstoječemu antidiabetičnemu in kardiovaskularnemu zdravljenju, v trajanju do 3,5 let.
Do not use this medicine after the expiry date which is stated on the carton and the blister pack after “EXP”. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in pretisnem omotu, poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
Since there is a potential for an increase in dose-related adverse events, a decrease in the dose of pioglitazone may be needed when gemfibrozil is concomitantly administered. 
Ker obstaja možnost povečanja od odmerka odvisnih neželenih učinkov, bo morda ob sočasnem dajanju gemfibrozila potrebno znižati odmerek pioglitazona.
See section 2 “Glustin contains lactose monohydrate”. 
Glejte poglavje 2 “Zdravilo Glustin vsebuje laktozo monohidrat”.
What you need to know before you take Glustin Do not take Glustin: 
Kaj morate vedeti, preden boste vzeli zdravilo Glustin
If you stop taking Glustin 
Če ste prenehali jemati zdravilo Glustin
Blood and lymphatic system disorders anaemia common 
Bolezni krvi in limfatičnega sistema anemija
as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin - a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. 
kot dvojno peroralno zdravljenje v kombinaciji: - z metforminom pri odraslih bolnikih (predvsem bolnikih s prekomerno telesno maso) z nezadostnim nadzorom glikemije kljub najvišjemu toleriranemu odmerku metformina v monoterapijis sulfonilsečnino, le pri odraslih bolnikih, ki ne prenašajo metformina ali je metformin pri njih kontraindiciran, z nezadostnim nadzorom glikemije kljub najvišjemu dovoljenemu odmerku sulfonilsečnine v monoterapiji.
Frequencies are defined as: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000); not known (cannot be estimated from the available data). 
Neželeni učinki, o katerih so poročali večkrat (> 0,5%) kot pri placebu in več kot enkrat pri bolnikih, ki so prejemali pioglitazon v dvojno slepih študijah, so našteti spodaj, in sicer po skupinah organskih sistemov in absolutni pogostnosti, kot je priporočeno po MedDRA. Pogostnosti so določene kot: zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do < 1/10); občasni (≥ 1/1.000 do < 1/100); redki (≥ 1/10.000 do < 1/1.000); zelo redki (< 1/10.000); neznana (ni mogoče oceniti iz razpoložljivih podatkov).
When activity, concentrations and protein binding are taken into account, pioglitazone and metabolite M-III 
Če upoštevamo aktivnost, koncentracije in vezavo na beljakovine, je delež učinkovitosti pioglitazona in presnovka M-III enak.
Reproductive system and breast disorders erectile dysfunction common 
Motnje reprodukcije in dojk erektilna disfunkcija
This medicine will not affect your ability to drive or use machines but take care if you experience abnormal vision. 
Vpliv na sposobnost upravljanja vozil in strojev To zdravilo ne vpliva na sposobnost upravljanja vozil strojev, vendar pa bodite pozorni v primeru pojava težav z vidom.
You may take your tablets with or without food. 
Zdravilo Glustin skupaj s hrano in pijačo Tablete lahko jemljete skupaj s hrano ali brez nje.
No dose adjustment is necessary in patients with impaired renal function (creatinine clearance >4 mL/min) (see section 5.2). 
Pri bolnikih z okvarjenim delovanjem ledvic (očistek kreatinina > 4 ml/min) odmerka ni treba prilagajati (glejte poglavje 5.2).
Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with Glustin and insulin experienced the development of heart failure. 
Pri nekaterih bolnikih z dolgotrajno sladkorno boleznijo tipa 2 in srčno boleznijo ali predhodno kapjo se je pri zdravljenju z zdravilom Glustin in insulinom pojavilo srčno popuščanje.
There may be an increased possibility of becoming pregnant because you may ovulate again when you take Glustin. 
Obstaja povečana možnost zanositve, saj se vam pri jemanju zdravila Glustin ovulacija lahko povrne.
common common common common common blood creatine phospho-kinase increased common increased lactic dehydro-genase uncommon alanine aminotransferase increased7 
povišana vrednost keratin fosfokinaze v krvi povišana vrednost laktatne dehidrogenaze občasni povišana vrednost alanin amino transferaze7
- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance. 
kot monoterapija - pri odraslih bolnikih (predvsem bolnikih s prekomerno telesno maso) nezadostno nadzorovanih z dieto in gibanjem, pri katerih je metformin, zaradi kontraindikacij ali neprenašanja, neprimeren.
4 A pooled analysis was conducted of adverse reactions of bone fractures from randomised, comparator controlled, double blind clinical trials in over 8,100 patients in the pioglitazone-treated groups and 7,400 in the comparator-treated groups of up to 3.5 years duration. 
4 Opravljena je bila skupna analiza neželenih učinkov zlomov kosti iz randomiziranih, s primerjalnim zdravilom kontroliranih, dvojno slepih kliničnih preskušanj pri več kot 8.100 bolnikov v skupini, zdravljeni s pioglitazonom in 7.400 v skupini, zdravljeni s primerjalnim zdravilom, ki so trajale do 3,5 let.
The usual starting dose is one tablet of 15 mg or of 30 mg of pioglitazone to be taken once daily. 
Običajni začetni odmerek je ena 15 miligramska ali 30-miligramska tableta pioglitazona enkrat na dan.
Glustin contains pioglitazone. 
Zdravilo Glustin vsebuje pioglitazon.
Metabolism and nutrition disorders hypo-glycaemia uncommon very common common appetite increased uncommon 
Presnovne in prehranske motnje hipoglikemija občasni zelo pogosti povečan apetit občasni
Each tablet contains 114.51 mg of lactose monohydrate (see section 4.4). 
Ena tableta vsebuje 114,51 mg laktoze monohidrata (glejte poglavje 4.4).
How to take Glustin 
Kako jemati zdravilo Glustin
Each tablet contains 92.87 mg of lactose monohydrate (see section 4.4). 
Ena tableta vsebuje 92,87 mg laktoze monohidrata (glejte poglavje 4.4).
Each tablet contains 76.34 mg of lactose monohydrate (see section 4.4). 
Ena tableta vsebuje 76,34 mg laktoze monohidrata (glejte poglavje 4.4).
Blurred vision due to swelling (or fluid) at the back of the eye has also been reported in patients taking Glustin (frequency cannot be estimated from the available data). 
Pri bolnikih, ki so jemali zdravilo Glustin, so poročali tudi o zamegljenem vidu zaradi otekanja (ali tekočine) očesnega ozadja (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti).
Bladder Cancer 
Rak sečnega mehurja
Concomitant administration of pioglitazone with gemfibrozil (an inhibitor of cytochrome P450 2C8) or with rifampicin (an inducer of cytochrome P450 2C8) is reported to increase or decrease, respectively, the plasma concentration of pioglitazone (see section 4.5) 
Poročali so, da sočasno dajanje pioglitazona z gemfibrozilom (zaviralcem citokroma P450 2C8) ali z rifampicinom (induktorjem citokroma P450 2C8) poviša oziroma zniža plazemsko koncentracijo pioglitazona (glejte poglavje 4.5).
Your blood sugar will be checked, and your dose of Glustin may need to be changed. 
Odmerek zdravila Glustin bo morda treba spremeniti.
Therapy with pioglitazone should not be initiated in patients with increased baseline liver enzyme levels (ALT >2.5 x upper limit of normal) or with any other evidence of liver disease. 
Pri bolnikih s povišanimi izhodiščnimi ravnmi jetrnih encimov (ALT > 2,5-kratna zgornja meja normalnih vrednosti) ali s kakršnimi koli drugimi znaki jetrne bolezni, zdravljenja s pioglitazonom ne smemo začeti.
Glustin should be used every day to work properly. 
Za pravilno delovanje morate zdravilo Glustin jemati vsak dan.